These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24461617)

  • 1. Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations.
    Calverley PM; Albert P; Walker PP
    Lancet Respir Med; 2013 Sep; 1(7):564-73. PubMed ID: 24461617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
    Walker PP; Calverley PM
    COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD.
    Molimard M; Bourcereau J; Le Gros V; Bourdeix I
    Respir Med; 2005 Jun; 99(6):695-702. PubMed ID: 15878485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
    Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
    Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S; Eberlein M; Eckhoff J; Schirren J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow and volume response to bronchodilator in patients with COPD.
    Vigna M; Aiello M; Bertorelli G; Crisafulli E; Chetta A
    Acta Biomed; 2018 Oct; 89(3):332-336. PubMed ID: 30333454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease.
    Zanini A; Cherubino F; Zampogna E; Croce S; Pignatti P; Spanevello A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1155-61. PubMed ID: 26124655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilator reversibility in COPD: the roguish but harmless little brother of airway hyperresponsiveness?
    Hansen EF; Vestbo J
    Eur Respir J; 2005 Jul; 26(1):6-7. PubMed ID: 15994382
    [No Abstract]   [Full Text] [Related]  

  • 10. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting inhaled bronchodilators in COPD: how many drugs do we need?
    Calverley PM
    Eur Respir J; 2005 Aug; 26(2):190-1. PubMed ID: 16055864
    [No Abstract]   [Full Text] [Related]  

  • 12. Airflow reversibility and long-term outcomes in patients with COPD without comorbidities.
    Marín JM; Ciudad M; Moya V; Carrizo S; Bello S; Piras B; Celli BR; Miravitlles M
    Respir Med; 2014 Aug; 108(8):1180-8. PubMed ID: 24933205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
    Chhabra SK; Bhatnagar S
    Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiotropium bromide: a long-acting anticholinergic bronchodilator for the treatment of patients with chronic obstructive pulmonary disease.
    Joos GF; Brusselle G; Derom E; Pauwels R
    Int J Clin Pract; 2003 Dec; 57(10):906-9. PubMed ID: 14712894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease.
    Albert P; Agusti A; Edwards L; Tal-Singer R; Yates J; Bakke P; Celli BR; Coxson HO; Crim C; Lomas DA; Macnee W; Miller B; Rennard S; Silverman EK; Vestbo J; Wouters E; Calverley P
    Thorax; 2012 Aug; 67(8):701-8. PubMed ID: 22696176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease.
    van Noord JA; Buhl R; Laforce C; Martin C; Jones F; Dolker M; Overend T
    Thorax; 2010 Dec; 65(12):1086-91. PubMed ID: 20978028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD.
    Celli BR; Tashkin DP; Rennard SI; McElhattan J; Martin UJ
    Respir Med; 2011 Aug; 105(8):1176-88. PubMed ID: 21531124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bronchial obstruction reversibility test in the assessment of COPD severity--controversies].
    Maskey-Warzechowska M; Pankowska M; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):68-71. PubMed ID: 17175980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilator reversibility in COPD.
    Hanania NA; Celli BR; Donohue JF; Martin UJ
    Chest; 2011 Oct; 140(4):1055-1063. PubMed ID: 21972384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.